Solace: Solace Therapeutics says 3rd trial of Vesair bladder device met endpoints

Solace Therapeutics today released data from a trial of its Vesair bladder control device, touting that the study met its endpoints "with statistical significance." The Framingham, Mass.-based company's Vesair bladder control device is comprised of a compressible air-filled balloon which acts as a "shock-abosrber" to slow rapid chanes in pressure that can cause Stress Urinary [...]The post Solace Therapeutics says 3rd trial of Vesair bladder device met endpoints appeared first on MassDevice.